Skip to content

Obstetric Outcome in Pregnancies Treated With Laparoscopic Cerclage

Obstetric Outcome in Pregnancies Treated With Laparoscopic Cerclage: an Observational Study in a Danish Cohort

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05863481
Enrollment
185
Registered
2023-05-18
Start date
2011-05-01
Completion date
2023-05-31
Last updated
2023-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Insufficiency, Pre-Term

Brief summary

Preterm birth is a leading cause of neonatal mortality and morbidity. Cervical insufficiency is one factor implicated in the complex mechanisms involved in spontaneous preterm birth. Trans-abdominal insertion of a cervical cerclage suture can be used to treat cervical insufficiency. Growing evidence support that laparoscopic cerclage procedures are safe and effective. Still, many aspects of the laparoscopic cerclage remains uncertain. Therefore, the investigators plan to study the obstetric outcome from the first and subsequent pregnancies after laparoscopic cerclage in a Danish cohort from Aarhus University Hospital in a 10 years' period.

Detailed description

Please see attached study protocol for further desricption.

Interventions

PROCEDURELaparoscopic cerclage placement

The surgical method of the laparoscopic cerclage procedure at Aarhus University Hospital previous described in a paper by Riiskjaer et al (DOI: 10.1111/aogs.12001)

Sponsors

University of Aarhus
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Persons who underwent laparoscopic cerclage at Aarhus University Hospital, Denmark between May 2011 and May 2021

Exclusion criteria

* Persons who had their laparoscopic cerclage performed subsequently to a trachelectomy.

Design outcomes

Primary

MeasureTime frameDescription
Neonatal survival (defined as survival at time of discharge from hospital)From birth until discharge, an average of 8 weeksno. (reported for first, and consecutive deliveries)

Secondary

MeasureTime frameDescription
Number of miscarriagesFrom the laparoscopic cerclage until May 1, 2023 (two years after the enrollment period ends)* Early miscarriages (\<16 weeks and 0 days) (no.) * Late miscarriages (\<22 weeks and 0 days) (no.)
DeliveriesFrom birth until discharge, an average of 8 weeks* Deliveries \<28 weeks and 0 days of an infant living (no.) * Deliveries \<32 weeks and 0 days of an infant living (no.) * Deliveries \<34 weeks and 0 days of an infant living (no.) * Deliveries \<37 weeks and 0 days of an infant living (no.) (reported for first, and consecutive deliveries)
Number of uterine rupturesFrom the laparoscopic cerclage until May 1, 2023 (two years after the enrollment period ends)no.
Time to first pregnancy (years and days)From the laparoscopic cerclage until May 1, 2023 (two years after the enrollment period ends)no.
Number of neonates surviving with major neonatal morbidityFrom birth until discharge, an average of 8 weeks* Necrotising enterocolitis (NEC) (no.) * Bronchopulmonary Dysplasia (BPD) (defined as respiratory/oxygen support at postmenstrual age (PMA) 36 weeks) (no.) * Intraventricular haemorrhage (IVH) Grade III and IV (no.) * Hydrocephalus with ventriculoperitoneal (VP) shunt (no.) * Periventricular leukomalacia (no.) * Retinopathy of prematurity (ROP) (no.) (Reported for first, and consecutive deliveries)
Number of pregnanciesFrom the laparoscopic cerclage until May 1, 2023 (two years after the enrollment period ends)no.

Other

MeasureTime frameDescription
Number of late complications from the laparoscopic cerclage procedureFrom the laparoscopic cerclage until May 1, 2023 (two years after the enrollment period ends)* Erosion into the vagina treated in hospital (no.) * Pain complaints from the stiches leading to intervention in pregnancy (no.) * Other complications from the cerclage leading to intervention in hospital (no.)
Neonatal characteristicsAt delivery* Gestational age (weeks and days) (no.) * Birthweight (grams) (Reported for deliveries with a gestational age ≥ 20 weeks and 0 days - allow missing data)
Number of early complications from the laparoscopic cerclage procedure30 days from the procedure* Conversion to laparotomy during surgery (no.) * Haemorrhage \> 500 ml (no.) * Postoperative infection treated at hospital (no.) * Damage to internal organs (no.) * Need for re-operation (no.) * Admission to Intensive Care Unit (no.) * Thromboembolic events (defined as deep vein thrombosis, pulmonary embolism or stroke) (no.) * Maternal cardiopulmonary arrest (no.) * Maternal death (no.)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026